United States · FDA National Drug Code directory
Deflazacort
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 70095-043_4583474c-40e7-dd9d-e063-6294a90a902a
- Product NDC
- 70095-043
- Form
- TABLET
- Composition / generic term
- Deflazacort
- Labeler
- Sun Pharmaceutical Industries, Inc.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20250319
- Source listing expiry
- 20261231
Source-listed ingredients
- DEFLAZACORT — 36 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 1 BOTTLE in 1 CARTON (70095-043-30) / 30 TABLET in 1 BOTTLE · 70095-043-30
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →